chlorpromazine has been researched along with fluspirilene in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (33.33) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Andrews, PR; Craik, DJ; Martin, JL | 1 |
| Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Golbraikh, A; Grulke, CM; Hajjo, R; Huang, XP; Roth, BL; Setola, V; Tropsha, A | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Easwaran, M; Manickam, M; Pillaiyar, T; Wendt, LL | 1 |
| Cuparencu, F; Feszt, G; Kun, I; Orbán, I | 1 |
| Koutras, DA; Martinos, A; Papachristou, DN; Rinieris, P; Souvatzoglou, A; Stefanis, C | 1 |
| Annable, L; Chouinard, G; Steinberg, S | 1 |
| O'Croinin, F; Zibin, T | 1 |
| Inoue, K; Ito, K; Koizumi, S; Nakazawa, K; Ohno, Y | 1 |
1 review(s) available for chlorpromazine and fluspirilene
| Article | Year |
|---|---|
The recent outbreaks of human coronaviruses: A medicinal chemistry perspective.
Topics: Antiviral Agents; Chemistry, Pharmaceutical; COVID-19; Disease Outbreaks; Drug Repositioning; Humans; Virus Internalization | 2021 |
1 trial(s) available for chlorpromazine and fluspirilene
| Article | Year |
|---|---|
A controlled clinical trial of fluspirilene, a long-acting injectable neuroleptic, in schizophrenic patients with acute exacerbation.
Topics: Adult; Age Factors; Basal Ganglia Diseases; Chlorpromazine; Clinical Trials as Topic; Double-Blind Method; Female; Fluspirilene; Humans; Injections, Intramuscular; Male; Prolactin; Random Allocation; Schizophrenia; Sex Factors; Spiro Compounds | 1986 |
10 other study(ies) available for chlorpromazine and fluspirilene
| Article | Year |
|---|---|
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Development, validation, and use of quantitative structure-activity relationship models of 5-hydroxytryptamine (2B) receptor ligands to identify novel receptor binders and putative valvulopathic compounds among common drugs.
Topics: Algorithms; Binding, Competitive; Databases, Factual; Dexfenfluramine; Drug-Related Side Effects and Adverse Reactions; Fenfluramine; Heart Valve Diseases; Ligands; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Radioligand Assay; Receptor, Serotonin, 5-HT2B; Serotonin 5-HT2 Receptor Agonists | 2010 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
The different influence of predominantly antiadrenergic and antidopaminergic neuroleptics on the estrous cycle in rats.
Topics: Animals; Chlorpromazine; Diestrus; Dose-Response Relationship, Drug; Estrus; Female; Fluspirilene; Methotrimeprazine; Phenothiazines; Pimozide; Pregnancy; Pseudopregnancy; Rats; Receptors, Adrenergic; Thioridazine; Tranquilizing Agents | 1977 |
Effects of six weeks' neuroleptic treatment on the pituitary-thyroid axis in schizophrenic patients.
Topics: Adolescent; Adult; Chlorpromazine; Circadian Rhythm; Fluspirilene; Humans; Male; Pituitary Gland; Prolactin; Schizophrenia; Spiro Compounds; Thyroid Gland; Thyrotropin; Thyrotropin-Releasing Hormone; Thyroxine; Triiodothyronine | 1986 |
Re: Replacement of chlorpromazine with other neuroleptics: effect on abnormal skin pigmentation and ocular changes.
Topics: Chlorpromazine; Chronic Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fluspirilene; Humans; Male; Middle Aged; Schizophrenia; Schizophrenic Psychology; Skin Pigmentation | 1994 |
Characterization of inhibition by haloperidol and chlorpromazine of a voltage-activated K+ current in rat phaeochromocytoma cells.
Topics: Animals; Antipsychotic Agents; Barium; Calcium Channels; Calmodulin; Chlorpromazine; Dopamine D2 Receptor Antagonists; Fluspirilene; GTP-Binding Proteins; Haloperidol; Ion Channel Gating; Membrane Potentials; PC12 Cells; Pimozide; Potassium; Potassium Channels; Rats | 1995 |